HIGHLIGHTS
- who: Immunohematol and collaborators from the Insurance Corporation Model Hospital, Ministry of labor, Noida, Uttar Pradesh, India have published the research work: Induced pluripotent stem cells: An update, in the Journal: (JOURNAL) of 11/01/2015
- what: Koji Eto, a blood stem_cell researcher at CiRA, headed the preclinical in_vivo and ex vivo studies focused on the length of time iMKPCs could be established prior to transfusion, while retaining their functional abilities and use of hiPSCs as a powerful research tool, with the potential of novel targeted therapeutics for hematopoietic disorders.
- future: A crucial . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.